Emerging Approaches to Predict Prognosis and Monitor Disease Progression in Lymphangioleiomyomatosis

Am J Respir Crit Care Med. 2019 Dec 1;200(11):1424-1426. doi: 10.1164/rccm.201906-1209RR.

Authors

Evelyn Lynn¹, Marissa O'Callaghan¹, Abhilash Sahadevan^{1

2}, Cormac McCarthy^{1

2}

Affiliations

¹ Department of Respiratory Medicine, St. Vincent's University Hospital, Dublin, Ireland; and.
² School of Medicine, University College Dublin, Dublin, Ireland.

PMID: 31618058
DOI: 10.1164/rccm.201906-1209RR

No abstract available

Publication types

Comment

MeSH terms

Biomarkers
Disease Progression
Humans
Lipopolysaccharides
Lymphangioleiomyomatosis*
National Heart, Lung, and Blood Institute (U.S.)
Prognosis
Prospective Studies
Registries
United States

Substances

Biomarkers
Lipopolysaccharides
lipoarabinomannan